[HTML][HTML] Role of cholinergic signaling in Alzheimer's disease

ZR Chen, JB Huang, SL Yang, FF Hong - Molecules, 2022 - mdpi.com
Acetylcholine, a neurotransmitter secreted by cholinergic neurons, is involved in signal
transduction related to memory and learning ability. Alzheimer's disease (AD), a progressive …

β− Arrestins: structure, function, physiology, and pharmacological perspectives

J Wess, AB Oteng, O Rivera-Gonzalez… - Pharmacological …, 2023 - ASPET
The two β-arrestins, β-arrestin-1 and-2 (systematic names: arrestin-2 and-3, respectively),
are multifunctional intracellular proteins that regulate the activity of a very large number of …

[HTML][HTML] Cholinergic system and its therapeutic importance in inflammation and autoimmunity

N Halder, G Lal - Frontiers in immunology, 2021 - frontiersin.org
Neurological and immunological signals constitute an extensive regulatory network in our
body that maintains physiology and homeostasis. The cholinergic system plays a significant …

[HTML][HTML] Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic

SE Yohn, PJ Weiden, CC Felder, SM Stahl - Trends in Pharmacological …, 2022 - cell.com
Modern interest in muscarinic acetylcholine receptor (mAChR) activators for schizophrenia
began in the 1990s when xanomeline, an M 1/M 4-preferring mAChR agonist developed for …

[HTML][HTML] From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer's disease

AJH Brown, SJ Bradley, FH Marshall, GA Brown… - Cell, 2021 - cell.com
Current therapies for Alzheimer's disease seek to correct for defective cholinergic
transmission by preventing the breakdown of acetylcholine through inhibition of …

Phosphorylation barcodes direct biased chemokine signaling at CXCR3

DS Eiger, JS Smith, T Shi, TM Stepniewski, CF Tsai… - Cell chemical …, 2023 - cell.com
G protein-coupled receptor (GPCR)-biased agonism, selective activation of certain signaling
pathways relative to others, is thought to be directed by differential GPCR phosphorylation" …

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease

L Dwomoh, GS Tejeda, AB Tobin - Neuronal Signaling, 2022 - portlandpress.com
Alzheimer's disease (AD) remains a major cause of morbidity and mortality worldwide, and
despite extensive research, only a few drugs are available for management of the disease …

G protein–biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model

Y Huang, T Rafael Guimarães… - Proceedings of the …, 2022 - National Acad Sciences
Biased G protein–coupled receptor (GPCR) ligands, which preferentially activate G protein
or β-arrestin signaling pathways, are leading to the development of drugs with superior …

[HTML][HTML] Fine tuning muscarinic acetylcholine receptor signaling through allostery and bias

ET Van der Westhuizen, KHC Choy, C Valant… - Frontiers in …, 2021 - frontiersin.org
The M1 and M4 muscarinic acetylcholine receptors (mAChRs) are highly pursued drug
targets for neurological diseases, in particular for Alzheimer's disease and schizophrenia …

[HTML][HTML] GPCRs in intracellular compartments: New targets for drug discovery

I Fasciani, M Carli, F Petragnano, F Colaianni, G Aloisi… - Biomolecules, 2022 - mdpi.com
The architecture of eukaryotic cells is defined by extensive membrane-delimited
compartments, which entails separate metabolic processes that would otherwise interfere …